![]() |
市场调查报告书
商品编码
1403380
2030 年点胶自动化机械市场预测:按产品、最终用户和地区进行全球分析Pharmacy Automation Machine Market Forecasts to 2030 - Global Analysis By Product, End User and By Geography |
根据 Stratistics MRC 的数据,2023 年全球药局自动化市场规模为 36.1 亿美元,预计预测期内复合年增长率为 9.5%,到 2030 年将达到 68.2 亿美元。
「药局自动化」一词描述如何在製药企业中使用自动化系统和技术来简化和增强与药品管理和分销相关的许多领域。处方笺匹配、电脑化库存管理、机器人配药设备和自动化包装解决方案都包含在这些系统中。
根据联合国《世界人口高龄化报告(2019)》,东亚和东南亚的老年人口将增加一倍,65岁及以上人口从2019年的2.606亿增加到2050年的550万。这一数字将增至近7250万人。
随着医疗保健产业采用电子健康记录(EHR) 和数位处方笺系统,将药房与数位平台整合至关重要。药房自动化促进了这一发展,药房自动化提供的技术可以根据电子健康资讯轻鬆监控、验证和分发处方笺。此外,它还可以帮助药局跟上不断变化的医疗保健法规和技术进步,同时提高用药准确性和病人安全,推动该市场的扩张。
许多药局的主要财务障碍是购买和安装自动化设备所需的高成本。较大的药局可能会犹豫是否引入自动化,因为投资回报时间会更长。此外,自动化的初始成本负担可能是接受的主要障碍,限制了该技术在製药业的广泛使用。
科技提供安全的处方处理、库存管理和病患监测,以提高病患的便利性和照护品质。药局自动化技术也使得准确、有效率地向远方患者分发药物成为可能。这就是药房采用和创新新的配药自动化解决方案的原因。这是由于对远端药房和远端服务的需求不断增加,从而推动了这一市场的扩张。
不同製造商的多个自动化系统之间潜在的互通性挑战是一大缺点。由于缺乏标准化而导致沟通和资料交换效率低下,从而导致药品给药中的错误和低效。此外,缺乏标准化不仅阻碍了扩充性和未来的改进,而且还使药房工作人员难以接受培训,因为他们必须学习如何使用许多系统,这将是一个障碍。
药房自动化市场受到了 COVID-19大流行的负面影响。前所未有的全球健康危机扰乱了整个医疗保健产业的供应链、计划延迟和财政资源紧张。许多药局面临采用或升级自动化技术的挑战,以解决病患数量增加、资源限制和供不应求紧迫问题。此外,关门和社交距离政策也减少了患者去药局的次数,影响了自动化解决方案的市场。
由于桌面尺寸较小的设备可以准确、快速地对锭剂和胶囊中的药物进行计数,因此自动桌面计数器部分预计将占据最大份额。自动桌上型计数器通常使用最尖端科技来快速且准确地计算药物单位,从而提高病患安全和业务效率。此外,这些技术的范例包括光学感测器、机器人和软体演算法。透过解决处方笺管理的关键要素,我们支持整个配药自动化业务的扩展并推动该领域的成长。
由于专为医院药房设计的先进自动化系统和技术,预计医院药房行业在预测期内将出现最高的复合年增长率。医院药局正在使用自动化进行库存管理、药品包装和药品配发,以简化流程并降低出错风险。准确、及时的给药对于大型医疗机构也至关重要,这些系统需要改善患者照护、降低成本并满足日益增长的医疗服务需求,是市场扩张的驱动力。
亚太地区在估计期间占据了最大的市场占有率,因为向药房提供财政援助和其他奖励的各种政府倡议对于推进药房自动化非常重要。印度、日本和中国等国家正在重视数位医疗活动,透过将药房自动化整合到更大的医疗保健生态系统中来促进创新和技术改进。此外,医疗保健提供者越来越多地投资于尖端自动化技术,以减少用药错误、改善库存管理并提高患者安全,从而推动该地区的增长。Masu。
预计欧洲在预测期内将经历最高的复合年增长率。这是因为远距医疗和远距处方服务已成为接受药物治疗的患者的普及。在欧洲,资料分析和人工智慧正在结合,以改善药品库存管理并准确预测需求。该地区是许多主要企业的所在地,包括 McKesson Corporation、Becton、Dickinson and Company、Capsa Healthcare 和 Cerner Corporation,为医疗保健提供者提供自动化解决方案,最大限度地减少错误并确保合规性。我们鼓励投资。
According to Stratistics MRC, the Global Pharmacy Automation Market is accounted for $3.61 billion in 2023 and is expected to reach $6.82 billion by 2030 growing at a CAGR of 9.5% during the forecast period. The term "pharmacy automation" describes how automated systems and technology are used in the pharmaceutical business to simplify and enhance a number of areas related to managing and distributing medications. Prescription verification, computerized inventory management, robotic dispensing equipment, and automated packaging solutions are all included in these systems.
According to the UN report on World Population Ageing (2019), Eastern and Southeastern Asia are expected to experience a two-fold increase in the number of geriatric individuals, with the population aged 65 years or over projected to increase from 260.6 million in 2019 to nearly 572.5 million by 2050.
Pharmacy integration with digital platforms is imperative as the healthcare sector embraces electronic health records (EHRs) and digital prescription systems. This development is made easier by pharmacy automation, which provides technologies that can effortlessly monitor, check, and dispenses prescriptions in accordance with electronic health information. In addition, this helps pharmacies stay up-to-date with changing healthcare regulations and technological advancements while also improving drug accuracy and patient safety which is driving this market expansion.
A major financial obstacle for many pharmacies may be the large expenditure needed to acquire and install automation equipment, which includes its high start-up expenses and higher medication filling fees. Slightly larger pharmacies may be discouraged from implementing automation due to the extended ROI time. Further, the initial price burden of automation can be a major barrier to acceptance, restricting the technology's widespread use in the pharmaceutical industry, which thereby hinders this market size.
To improve patient convenience and care quality, technologies provide safe prescription processing, inventory management, and patient monitoring which are done online due to these services, which help pharmacies expand their reach beyond physical locations. Medicines can be accurately and efficiently dispensed to patients who live far away, because in large part to pharmacy automation technologies. Therefore, pharmacies are adopting and innovating new pharmacy automation solutions because of the growing need for telepharmacy and distant services thereby propelling this market expansion.
The possibility of challenges with interoperability between multiple automation systems from different manufacturers is one major disadvantage. Ineffective communication and data interchange caused by this lack of standardization result in mistakes and inefficiencies in the administration of medications. Additionally, inadequate standardization can impede scalability and future improvements, as well as make it more difficult for pharmacy staff to receive training because they must learn to use many systems that hamper this market expansion.
The pharmacy automation market has been negatively impacted by the COVID-19 pandemic. The unprecedented global health crisis disrupted supply chains, delayed projects, and strained financial resources across the healthcare sector. Many pharmacies faced challenges in adopting or upgrading automation technologies as they grappled with immediate concerns such as increased patient loads, resource constraints, and supply shortages. Furthermore, lockdowns and social distancing policies also decreased patient visits to pharmacies, which had an impact on the market for automation solutions.
The automated table-top counters segment is estimated to hold the largest share due to small, desktop-sized devices that count pills or capsules of medication precisely and quickly. They usually use cutting-edge technology to swiftly and precisely count medicine units, improving patient safety and operational effectiveness. Furthermore, examples of these technologies include optical sensors, robotics, and software algorithms. By addressing a critical component of prescription administration, they support the expansion of the pharmacy automation business as a whole, which is boosting this segment's growth.
The hospital pharmacy segment is anticipated to have the highest CAGR during the forecast period due to advanced automated systems and technologies designed for usage in hospital pharmacy settings. Hospital pharmacies use automation to manage inventories, package medications, and compound medications, which streamlines processes and lowers mistake risk. In addition, large medical facilities are in need of these systems because accurate and timely medicine administration is crucial, and in order to improve patient care, cut expenses, and satisfy the growing demand for healthcare services that drives this market expansion.
Asia Pacific commanded the largest market share during the extrapolated period owing to various government initiatives have been significant in advancing pharmacy automation which, provid financial aid and other incentives to pharmacies. Countries such as India, Japan and China contribute in emphasizing digital health activities that promotes innovation and technological improvements by integrating pharmacy automation into larger healthcare ecosystems. In addition, to mitigate medication errors, improve inventory management, and enhance patient safety is pushing healthcare providers to invest in cutting-edge automation technologies thereby driving this region's growth.
Europe is expected to witness highest CAGR over the projection period, owing to telepharmacy and remote prescription services have become more popular for patients to get pharmaceutical care. Data analytics and artificial intelligence have been combined in Europe to improve pharmaceutical inventory management and precisely forecast demand. This region is home to many major key players such as McKesson Corporation, Becton, Dickinson and Company, Capsa Healthcare and Cerner Corporation have encouraged healthcare providers to invest in automation solutions that minimize errors and ensure compliance which are boosting this region's expansion.
Some of the key players in the Pharmacy Automation Market include Accu-Chart Plus Healthcare System Inc., Arxium Inc., Avery Weigh-Tronix , Becton, Dickinson, and Company, PerceptiMed Inc., Capsa Solutions LLC, Swisslog Holdings AG, Cerner Corporation, McKesson Corporation, Omnicell Inc., Yuyama Co. Ltd, Parata Systems LLC, Scriptpro LLC and Rxsafe LLC.
In June 2023, BD (Becton, Dickinson and Company), a leading global medical technology company, announced the worldwide commercial launch of a new automated instrument that prepares samples for clinical diagnostics using flow cytometry, enabling a complete "walkaway" workflow solution designed to improve standardization and reproducibility in cellular diagnostics.
In May 2023, Omnicell, Inc. announced changes to its leadership structure designed to create a more streamlined organization with a continued focus on operational excellence, driving continuous improvements in customer experience and the delivery of Omnicell's long-term commitments.
In April 2023, BD (Becton, Dickinson and Company), a leading global medical technology company, launched a new, easy-to-use advanced ultrasound device with a specialized probe designed to provide clinicians with optimal IV placement.
In October 2022, Omnicell, Inc, a leading provider of medication management and adherence tools for health systems and pharmacies, announced the launch of Specialty Pharmacy Services, a turnkey offering with dedicated services to set up, operate, and optimize a specialty pharmacy program.